Liraglutide, a long-acting human glucagon-like peptide-1 analog, given as monotherapy significantly improves glycemic control and lowers body weight without risk of hypoglycemia in patients with type 2 diabetes.
作者信息
Vilsbøll Tina, Zdravkovic Milan, Le-Thi Tu, Krarup Thure, Schmitz Ole, Courrèges Jean-Pierre, Verhoeven Robert, Bugánová Ingrid, Madsbad Sten
机构信息
Department of Internal Medicine, Gentofte Hospital, Hellerup, Denmark.
出版信息
Diabetes Care. 2007 Jun;30(6):1608-10. doi: 10.2337/dc06-2593. Epub 2007 Mar 19.
PMID:17372153
Abstract
摘要
Zotero 插件